{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:17:21Z","timestamp":1770815841912,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL151867"],"award-info":[{"award-number":["K23HL151867"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.iccl.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T19:31:10Z","timestamp":1655148670000},"page":"279-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Contemporary Management of Refractory Angina"],"prefix":"10.1016","volume":"11","author":[{"given":"Rebekah","family":"Lantz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odayme","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Mattingly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy D.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccl.2022.03.002_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/euhj.2001.2706","article-title":"The problem of chronic refractory angina","volume":"23","author":"Mannheimer","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrcardio.2013.200","article-title":"Treatment of refractory angina in patients not suitable for revascularization","volume":"11","author":"Henry","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2019.08.055","article-title":"Refractory angina, from pathophysiology to new therapeutic nonpharmacological technologies","volume":"13","author":"Gallone","year":"2020","journal-title":"JACC Cardiovascl Interv"},{"key":"10.1016\/j.iccl.2022.03.002_bib4","doi-asserted-by":"crossref","first-page":"e009002","DOI":"10.1161\/CIRCINTERVENTIONS.120.009002","article-title":"Therapeutic approaches for the no-option refractory angina patient","volume":"14","author":"Povsic","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"issue":"2 Suppl","key":"10.1016\/j.iccl.2022.03.002_bib5","first-page":"S50","article-title":"Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification","volume":"29","author":"Jolicoeur","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2018.04.061","article-title":"Coronary microvascular dysfunction in patients with stable coronary artery disease: the CE-MARC 2 coronary physiology sub-study","volume":"266","author":"Corcoran","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib7","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2022.03.002_bib8","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib9","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","volume":"34","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4244\/EIJY20M07_01","article-title":"An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International","volume":"16","author":"Kunadian","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2022.03.002_bib11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and No Obstructive Coronary Artery Disease (INOCA): developing Evidence-Based Therapies and Research Agenda for the Next Decade","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib12","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.107.726562","article-title":"Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib13","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women\u2019s Ischemia Syndrome Evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib14","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC State-of-the-art review","volume":"78","author":"del Buono","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib15","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.4244\/EIJ-D-18-00982","article-title":"The functional assessment of patients with non-obstructive coronary artery disease: expert review from an international microcirculation working group","volume":"14","author":"Widmer","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2022.03.002_bib16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"issue":"2 Pt 2","key":"10.1016\/j.iccl.2022.03.002_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.60.2.1","article-title":"Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries","volume":"60","author":"Campeau","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/CIRCULATIONAHA.119.039797","article-title":"Guiding principles for chronic total occlusion percutaneous coronary intervention: a global expert consensus document","volume":"140","author":"Brilakis","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib19","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/usc.2020.10","article-title":"Percutaneous coronary intervention for chronic total occlusion","volume":"14","author":"Vescovo","year":"2020","journal-title":"US Cardiol Rev"},{"key":"10.1016\/j.iccl.2022.03.002_bib20","first-page":"470","article-title":"Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery","volume":"98","author":"Mohamed","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2022.03.002_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2018.11.001","article-title":"Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study","volume":"73","author":"Farkouh","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib22","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.jacc.2008.09.010","article-title":"Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial","volume":"52","author":"Daemen","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","article-title":"Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial","volume":"55","author":"Kapur","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib24","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.107.711911","article-title":"Cardiac Allograft Vasculopathy: Recent Developments","volume":"117","author":"Schmauss","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib25","volume":"vol. 1","author":"Shetty","year":"2021"},{"key":"10.1016\/j.iccl.2022.03.002_bib26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-5223(99)70006-1","article-title":"Angiographic quantification of diffuse coronary artery disease: reliability and prognostic value for bypass operations","volume":"118","author":"Graham","year":"1999","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.iccl.2022.03.002_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MCA.0b013e3283239819","article-title":"Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: a population based study in Olmsted, Minnesota","volume":"20","author":"Kiernan","year":"2009","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.iccl.2022.03.002_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.RES.0000049104.57549.03","article-title":"Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function and oxygen consumption at rest","volume":"92","author":"Fallovollita","year":"2003","journal-title":"Circ Res"},{"issue":"Suppl O","key":"10.1016\/j.iccl.2022.03.002_bib29","doi-asserted-by":"crossref","first-page":"O2","DOI":"10.1016\/S1520-765X(01)90147-6","article-title":"Changes in cardiac metabolism: a critical step from stable angina to ischaemic cardiomyopathy","volume":"3","author":"Standley","year":"2001","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.iccl.2022.03.002_bib30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0002-9149(99)00387-2","article-title":"Direct myocardial revascularization and angiogenesis\u2014how many patients might be eligible?","volume":"84","author":"Mukherjee","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib31","first-page":"886","article-title":"Patients with coronary artery disease not amenable to traditional revascularization: Prevalence and 3-year mortality","volume":"75","author":"Williams","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2022.03.002_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejcnurse.2006.01.003","article-title":"Pharmacological Treatment and Perceived Health Status During 1-Year Follow Up in Patients Diagnosed with Coronary Artery Disease, But Ineligible for Revascularization: Results from the Euro Heart Survey on Coronary Revascularization","volume":"5","author":"Lenzen","year":"2006","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.iccl.2022.03.002_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.carrev.2019.01.012","article-title":"CD34+ Cell therapy for no-option refractory disabling angina: time for FDA approval?","volume":"20","author":"Benck","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.iccl.2022.03.002_bib34","first-page":"1215","article-title":"Revascularization in \u201cno option\u201d patients with refractory angina: Frequency, etiology and outcomes","volume":"92","author":"Sharma","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2022.03.002_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mhj.2001.115786","article-title":"Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization","volume":"142","author":"Mukherjee","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ahj.2009.10.013","article-title":"Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease","volume":"158","author":"Cavender","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib37","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/eurheartj\/ehq133","article-title":"Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?","volume":"31","author":"Deanfield","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the I(f) current inhibitor ivabradine in patient with stable angina receiving beta-blocker therapy: a 4-month, andomized, double-blind, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"issue":"9641","key":"10.1016\/j.iccl.2022.03.002_bib39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.iccl.2022.03.002_bib40","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1136\/heart.85.6.e9","article-title":"Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management","volume":"85","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.iccl.2022.03.002_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.iccl.2022.03.002_bib42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2020.05.020","article-title":"Long-Term (3 Years) Outcomes of ranolazine therapy for refractory angina pectoris (from the Ranolazine Refractory Registry)","volume":"129","author":"Storey","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib44","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1053\/euhj.2001.2896","article-title":"Combination treatment in stable effort angina using trimetazidine and metoprolol. Results of a randomized, double-blind, multicentre study (TRIMPOL II)","volume":"22","author":"Szwed","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5830\/CVJA-2016-068","article-title":"Xanthine oxidase inhibitors in ischaemic heart disease","volume":"28","author":"Zdenghea","year":"2017","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.iccl.2022.03.002_bib46","first-page":"2297","article-title":"Opioid treatment of pain in angina pectoris","volume":"164","author":"Hermann","year":"2002","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.iccl.2022.03.002_bib47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/CRD.0b013e31820e8106","article-title":"Depression and cardiac disease: a review","volume":"19","author":"Celano","year":"2011","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.iccl.2022.03.002_bib48","series-title":"Practice guideline for the treatment of patients with major depressive disorder","year":"2010"},{"key":"10.1016\/j.iccl.2022.03.002_bib49","series-title":"The maudsley prescribing guidelines in psychiatry","author":"Taylor","year":"2015"},{"key":"10.1016\/j.iccl.2022.03.002_bib50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncpcardio0691","article-title":"Primer: practical approach to the selection of patients for and application of EECP","volume":"3","author":"Michaels","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.iccl.2022.03.002_bib51","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ahj.2008.07.024","article-title":"Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina","volume":"156","author":"Campbell","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib52","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.hlc.2016.04.013","article-title":"Increases in cardiac output and oxygen consumption during enhanced external counterpulsation","volume":"25","author":"Ahlbom","year":"2016","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.iccl.2022.03.002_bib53","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib54","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/heart.89.8.830","article-title":"Enhanced external counterpulsation for refractory angina pectoris","volume":"89","author":"Sinvhal","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.iccl.2022.03.002_bib55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.carrev.2014.10.011","article-title":"The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina","volume":"16","author":"Alunni","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.iccl.2022.03.002_bib56","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1755-5922.2012.00313.x","article-title":"Cardiac shock wave therapy for chronic refractory angina pectoris. A prospective placebo-controlled randomized trial","volume":"31","author":"Schmid","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.iccl.2022.03.002_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12471-016-0821-y","article-title":"Cardiac shockwave therapy in patients with chronic refractory angina pectoris","volume":"24","author":"Vainer","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib58","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1253\/circj.CJ-09-1028","article-title":"Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris","volume":"74","author":"Kikuchi","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.iccl.2022.03.002_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12947-017-0102-y","article-title":"Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis","volume":"15","author":"Burneikaite","year":"2017","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.iccl.2022.03.002_bib60","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1053\/euhj.2002.3286","article-title":"Long-term effects of spinal cord stimulation and coronary artery bypass grafting on quality of life and survival in the ESBY study","volume":"23","author":"Ekre","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib61","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1525-1403.2012.00452.x","article-title":"Spincal cord stimulation therapy for patients with refractory angina who are not candidates for revascularization","volume":"15","author":"Zipes","year":"2012","journal-title":"Neuromodulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib62","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.CIR.0000061911.47710.8A","article-title":"VIVA Investigators. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis","volume":"107","author":"Henry","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib63","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/hc0802.104407","article-title":"Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial","volume":"105","author":"Simons","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib64","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2007.06.010","article-title":"Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials","volume":"50","author":"Henry","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib65","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.gt.3302802","article-title":"Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment","volume":"13","author":"Stewart","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.iccl.2022.03.002_bib66","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: a Phase I\/IIa Double-Blind, Randomized Controlled Trial","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib67","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, Autologous CD34+ Cell therapy for refractory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.iccl.2022.03.002_bib68","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","article-title":"The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina","volume":"9","author":"Povsic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2022.03.002_bib69","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/eurheartj\/ehx764","article-title":"Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials","volume":"9","author":"Henry","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib70","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3390\/cells10051137","article-title":"Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair\u2014A Systematic Review","volume":"10","author":"Rai","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.iccl.2022.03.002_bib71","doi-asserted-by":"crossref","first-page":"e010802","DOI":"10.1161\/CIRCINTERVENTIONS.121.010802","article-title":"Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction","volume":"15","author":"Henry","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2022.03.002_bib72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13287-018-0969-z","article-title":"Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)","volume":"9","author":"Bassetti","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.iccl.2022.03.002_bib73","doi-asserted-by":"crossref","first-page":"e64669","DOI":"10.1371\/journal.pone.0064669","article-title":"Bone marrow stem cell treatment for ischemic heart disease in patients with no option of revascularization: a systematic review and meta-analysis","volume":"8","author":"Fisher","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.iccl.2022.03.002_bib74","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ahj.2010.04.015","article-title":"Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis","volume":"160","author":"Joyal","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib75","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"A\u00a0randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions","volume":"39","author":"Werner","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2022.03.002_bib76","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.118.031313","article-title":"Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion","volume":"139","author":"Lee","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2022.03.002_bib77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2018.06.116","article-title":"Safety and efficacy of the reducer: a multi-center clinical registry - REDUCE study","volume":"269","author":"Giannini","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib78","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcin.2018.01.251","article-title":"Coronary sinus reducer implantation for the treatment of chronic refractory angina: a single center experience","volume":"11","author":"Giannini","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.iccl.2022.03.002_bib79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2022.03.002_bib80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00129784-200202040-00005","article-title":"Transmyocardial laser revascularization: a review of basic and clinical aspects","volume":"2","author":"Szatkowski","year":"2002","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.iccl.2022.03.002_bib81","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2005.06.079","article-title":"A\u00a0blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease","volume":"46","author":"Leon","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib82","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.jacc.2012.07.012","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2022.03.002_bib83","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21925\/mplsheartjournal-D-18-00008","article-title":"Health status and quality of life of patients enrolled in a specialized refractory angina clinic","volume":"2","author":"Bennett","year":"2019","journal-title":"J\u00a0Minneapolis Heart Inst Found"},{"key":"10.1016\/j.iccl.2022.03.002_bib84","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1161\/CIRCRESAHA.119.315138","article-title":"More data than options for the \u201cno-option\u201d refractory angina patient in the United States","volume":"124","author":"Riley","year":"2019","journal-title":"Circ Res"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221174582200027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221174582200027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:00:43Z","timestamp":1761933643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221174582200027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S221174582200027X"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2022.03.002","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Management of Refractory Angina","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}